Breakthroughs in advances in endocrine research and molecular endocrinology are revolutionizing the diagnosis and treatment of metabolic diseases. The discovery of novel hormone signaling pathways has deepened understanding of insulin resistance and beta-cell dysfunction. Molecular research has also identified genetic markers linked to endocrine disorders, paving the way for personalized medicine. Gene-editing technologies, including CRISPR, are being explored for their potential in correcting inherited hormonal deficiencies. Emerging therapies targeting hormonal receptors offer new treatment avenues for diabetes and obesity-related conditions. By combining molecular endocrinology with clinical applications, scientists are developing innovative strategies to improve endocrine health and metabolic stability.
Submit your abstract Today
